Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-15
DOI
10.1038/s41598-021-97787-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct Cardiac Actions of the Sodium Glucose Co‐Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure‐Overload Heart Failure
- (2021) Xuan Li et al. Journal of the American Heart Association
- Re-epithelialization and immune cell behaviour in an ex vivo human skin model
- (2020) Ana Rakita et al. Scientific Reports
- Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stress
- (2020) Milton Packer CARDIOVASCULAR RESEARCH
- SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
- (2020) So Ra Kim et al. Nature Communications
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure
- (2020) Carlos G. Santos-Gallego et al. JACC-Cardiovascular Imaging
- Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
- (2019) Roni Nielsen et al. CIRCULATION
- p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia
- (2019) Masataka Yokoyama et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
- (2019) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation
- (2019) Alex Ali Sayour et al. Journal of Translational Medicine
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of sodium‐glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions
- (2019) Nick S.R. Lan et al. ESC Heart Failure
- Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection
- (2019) David Z. Cherney et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin
- (2019) Chuangyu Wen et al. Cell Death & Disease
- Nitric oxide signalling in cardiovascular health and disease
- (2018) Charlotte Farah et al. Nature Reviews Cardiology
- Pathophysiological Mapping of Experimental Heart Failure: Left and Right Ventricular Remodeling in Transverse Aortic Constriction Is Temporally, Kinetically and Structurally Distinct
- (2018) Mathew J. Platt et al. Frontiers in Physiology
- Boysenberry polyphenol inhibits endothelial dysfunction and improves vascular health
- (2018) Ryo Furuuchi et al. PLoS One
- Gamma-Aminobutyric Acid Signaling in Brown Adipose Tissue Promotes Systemic Metabolic Derangement in Obesity
- (2018) Ryutaro Ikegami et al. Cell Reports
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- SIRT1 protects against myocardial ischemia–reperfusion injury via activating eNOS in diabetic rats
- (2015) Mingge Ding et al. Cardiovascular Diabetology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease
- (2014) Ryosuke Kikuchi et al. NATURE MEDICINE
- Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity
- (2014) Masataka Yokoyama et al. Cell Reports
- p53-Induced Adipose Tissue Inflammation Is Critically Involved in the Development of Insulin Resistance in Heart Failure
- (2012) Ippei Shimizu et al. Cell Metabolism
- Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents
- (2010) Ippei Shimizu et al. JOURNAL OF CLINICAL INVESTIGATION
- Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry
- (2009) A. Hirayama et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started